Lung Cancer

Lung cancer remains the most diagnosed cancer worldwide and a leading cause of cancer-related deaths (GLOBOCAN 2022). Although its mortality rate remains high, recent advances in pharmacotherapy, along with a widening range of diagnostic and treatment options, including platinum-based chemotherapy and targeted oral therapies for oncogene-addicted patients, have significantly improved outcomes and brought new hope.

At NanoAlvand, we are proud to support this progress by offering a portfolio of essential therapies, including:

Carbonatin® (carboplatin), Alvoxal® (oxaliplatin), Alvopem® (pemetrexed), Alvotere® (docetaxel), Alvopax® (paclitaxel), Tiagem® (gemcitabine), Winobin® (vinorelbine), Cabotax® (cabazitaxel), Mertisso® (osimertinib)

Because wherever hope is needed, NanoAlvand is there and we believe that our hope shapes the future.

🌿 On this World Lung Cancer Day (1st August), we stand with patients, families, and caregivers working together so that every breath becomes a symbol of life, resilience, and hope.